Hospira to Present at the Bank of America 2008 Health Care Conference on May 14

LAKE FOREST, Ill., April 30 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at the Bank of America 2008 Health Care Conference on Wednesday, May 14, 2008, at the Four Seasons Hotel in Las Vegas.

The presentation is scheduled to begin at 12:40 p.m. Pacific time on Wednesday, May 14, 2008. It will be open to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site at 12:25 p.m. Pacific time on May 14, 2008. A replay will be available on the Hospira Web site approximately 24 hours after the live presentation, until May 21.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.

SOURCE Hospira, Inc.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.